O’Ryan Health
O'Ryan Health is a pediatric health technology company providing at-home capillary blood collection and laboratory testing for children via its Artemis Platform and RedDrop ONE device. It serves families through direct-to-parent wellness kits, Medicaid and RHTP government programs, healthcare organization partnerships, and pediatric research studies.
- Company typePrivate
- Founded2022
- HeadquartersWellesley, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What O’Ryan Health does
O'Ryan Health is a privately-held pediatric health technology company headquartered at 33 Kirkland Circle, Wellesley, Massachusetts, that provides at-home capillary blood collection and laboratory testing services for children and families in the United States. The company operates the Artemis Platform, an end-to-end logistics and informatics system that manages virtual enrollment, guided collection via the validated RedDrop ONE capillary device, and compliant sample transport to CLIA-certified laboratory partners including Aura Genetics (CLIA-certified, CAP-accredited, Louisville, Kentucky), Celesta Health, and Meridian Valley Lab. Results are delivered through a secure Parent Portal that can be shared with a child's healthcare team, and the company explicitly excludes the European Union from its geographic footprint.
The company runs three concurrent go-to-market motions: a direct-to-parent product-led channel through the Parent Portal and Superhero Shop selling allergy (IgE), food sensitivity (IgG4), and routine wellness kits on minimum 6-month subscriptions (HSA/FSA eligible as of May 2026); an enterprise field sales channel targeting state Medicaid programs and Rural Health Transformation Programs via a fixed-cost standardized kit model; and a community-led motion leveraging IRB-approved pediatric research studies spanning medulloblastoma, autism spectrum disorder, juvenile dermatomyositis, and healthy kids cohorts. Revenue streams therefore include recurring DTC subscriptions, multi-year government program contracts, and managed-services partnerships with healthcare organizations supporting value-based care models.
Recent strategic activity is dense: partnerships with Aura Genetics (March 2026), Celesta Health (February 2026), Molecule Science Foundation (twice in May 2026), and BlueSavant AI (May 2026), plus the national launch of direct-to-parent testing (February 2026) and HSA/FSA approval (May 2026). The company is led by co-founder Tim Coleman (Architect of Operations). No revenue figures, funding rounds, or headcount have been disclosed in the available data, and the company does not report a public listing.
O’Ryan Health firmographics
Firmographics- Name
- O’Ryan Health
- Legal name
- O'Ryan Health Inc.
- Website
- https://oryan.health
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- O'Ryan Health is a pediatric health technology company providing at-home capillary blood collection and laboratory testing for children via its Artemis Platform and RedDrop ONE device. It serves families through direct-to-parent wellness kits, Medicaid and RHTP government programs, healthcare organization partnerships, and pediatric research studies.
- Ownership category
- akta.pro rank
O’Ryan Health industry classification
Industry- Product category
- Pediatric At-Home Diagnostic Testing
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Home Health Care Services (8082), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN)
- akta.pro secondary industry
- Pediatrics & Adolescent Medicine Practices (HLAFAJAF)
Keywords
Where O’Ryan Health is headquartered
LocationHeadquarters
- HQ city
- Wellesley
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
O’Ryan Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales
Revenue model
- Direct-to-Parent Wellness Kit Sales: Parents purchase wellness kits for food sensitivities, airborne allergens, and routine blood testing through the Superhero Shop in the Parent Portal. Now HSA/FSA eligible, removing cost barriers for families. Subscription model with minimum 6-month terms, payable monthly or annually.
- Medicaid and Government Program Contracts: Partnerships with states implementing Rural Health Transformation Programs (RHTP) to deliver at-home pediatric diagnostic access for rural and underserved communities under Medicaid. Fixed-cost standardized diagnostic kit model with predictable, auditable expenses scaling with program participation.
- Healthcare Organization Partnerships: Partnerships with healthcare organizations and value-based care programs providing home-based diagnostic access. Laboratory testing performed by partners (Celesta Health, Aura Genetics, Meridian Valley Lab) with results delivered through O'Ryan Health's platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Wellness Kits - Direct-to-Parent |
| Subscription | Multi-year contract | Medicaid/Government Program Kits |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
O’Ryan Health product offering
Product offeringCore offering
O'Ryan Health enables parents to collect small capillary blood samples from children at home using the RedDrop ONE device, then ships those samples via its Artemis logistics platform to CLIA-certified laboratory partners (Meridian Valley Lab, Celesta Health, Aura Genetics) for allergy, food sensitivity, and routine pediatric wellness testing. Results are returned to families through a secure Parent Portal and can be shared with the child's healthcare team. The company also provides at-home pediatric diagnostic infrastructure to state Medicaid Rural Health Transformation Programs and conducts IRB-approved pediatric research studies.
Product overview
O'Ryan Health is a pediatric-focused health technology company providing at-home blood collection and laboratory access for children through its Artemis Platform and Parent Portal. The core offering consists of the RedDrop ONE capillary blood collection device paired with laboratory testing services (via partners Meridian Valley Lab, Celesta Health, and Aura Genetics) for allergy, food sensitivity, and wellness testing. The company operates a direct-to-consumer model where parents order testing kits, collect blood samples at home, and receive results through the Parent Portal which can be shared with healthcare providers. O'Ryan Health also conducts multiple pediatric research studies (medulloblastoma, autism, JDM, healthy kids) using the same at-home collection infrastructure. Recent expansions include HSA/FSA eligibility for wellness kits, partnerships for rural health programs, and research collaborations for autism and JDM using AI analysis.
Differentiator
Problem solved
Functional benefit
Brands
- Artemis Platform: Logistics and informatics platform for pediatric diagnostic access, managing enrollment, kit logistics, sample transport, and result delivery.
- RedDrop ONE
- FoodSafe IgG4
- Inhalant Allergen IgE Profile
Products and services
- Artemis Platform End-to-end logistics and informatics platform managing virtual enrollment, guided blood sample collection, compliant sample transport to CLIA-certified laboratories, and result delivery; integrates with UPS logistics and is offered to Medicaid programs and healthcare organizations as infrastructure for home-based pediatric diagnostics.
- RedDrop ONE Device Capillary blood collection device that sticks to a child's arm or leg and provides a quick, nearly painless pinch to collect small blood samples, enabling safe parent-administered at-home blood collection validated across 19 U.S. states.
- Parent Portal Secure digital platform where families register, order wellness and allergy test kits through the Superhero Shop, access test results, manage their family's testing history, and download/share results with healthcare teams; HSA/FSA eligible purchasing available.
- Inhalant Allergen IgE Profile Laboratory test panel assessing reactions to 27 common airborne allergens including pollen, mold, and animal dander; results reported quantitatively in kU/L with population-based percentile interpretation.
- FoodSafe IgG4 95 Pediatric Allergan Test Kit Laboratory test evaluating delayed immune responses (IgG4) to 94 common foods plus Candida to detect food sensitivities associated with fatigue, headaches, digestive discomfort, and skin irritation.
- FoodSafe IgG4 190 Combo Pediatric Allergan Test Kit Expanded food sensitivity testing across 189 foods plus Candida, covering grains, dairy, meats, seafood, fruits, vegetables, herbs, spices, nuts, and additives; semi-quantitative reporting categorized as Low, Moderate, or High.
- Wellness Kit Subscriptions Subscription-based wellness kits offered to parents covering food sensitivity, airborne allergen, and routine blood testing; minimum 6-month subscription terms, payable monthly or 100% annually; HSA/FSA eligible.
Quantifiable outcome
- High first-attempt success rates with low reported pain and short collection times
- +3 more outcomes
Companies that use O’Ryan Health
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
O’Ryan Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability2 records
Feature3 records
O’Ryan Health partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered flagship and core.
- Molecule Science FoundationflagshipResearch partnership to build the largest decentralized bulk RNA dataset for Autism Spectrum Disorder (ASD). Molecule Science Foundation provides legal and technical infrastructure mobilizing a community of contributors around a coordinated charitable fundraise. O'Ryan Health's Artemis Platform enables decentralized collection of pediatric blood samples at scale. The study will enroll children with confirmed ASD diagnosis and neurotypical children as comparison cohort, generating approximately 200 RNA expression profiles.
- BlueSavant AIflagshipPartnership with O'Ryan Health and Molecule Science Foundation to advance autism research. BlueSavant AI's proprietary models analyze bulk RNA expression data to identify biological patterns associated with ASD. Collaboration combines high-quality, real-world RNA collected directly from families at home with BlueSavant AI's Autism AI model trained on large transcriptomic datasets.
- Molecule Science FoundationflagshipResearch partnership to build the largest decentralized single-cell immune dataset for Juvenile Dermatomyositis (JDM), a rare and serious pediatric autoimmune condition. Families collect small-volume blood samples at home using RedDrop ONE device; samples are transformed into single-cell RNA sequence data called 'Immune Avatars' serving as digital models of a child's immune system. IRB-approved study creates contiguous understanding of pathogenic immune signals driving JDM.
- Aura GeneticscoreStrategic partnership to deliver at-home pediatric capillary blood testing for Rural Health Transformation Programs. O'Ryan Health provides the Artemis Platform logistics infrastructure; Aura Genetics processes samples at its new CLIA-certified automated testing facility in Louisville, Kentucky with capacity to process tens of thousands of samples per day. Partnership supports states implementing RHTP by delivering convenient, secure at-home blood testing for children in rural and underserved communities.
- Meridian Valley LabcoreCLIA-certified clinical laboratory (operating since 1976) performs allergy and food sensitivity testing for O'Ryan Health's direct-to-parent testing program. Provides FoodSafe IgG4 panels (94 and 189 foods + Candida) and Inhalant Allergen IgE Profile assessing 27 common airborne allergens with quantitative reporting.
- Celesta HealthcorePartnership to make routine pediatric wellness blood testing available in the home. Celesta Health performs laboratory testing; O'Ryan Health provides at-home collection infrastructure using RedDrop ONE device. Results delivered to O'Ryan Health Parent Portal, enabling families to securely access and share information with their child's care team.
- RedDrop DxcoreManufacturer of the RedDrop ONE capillary blood collection device used for parent-administered at-home pediatric blood collection. Funded the IRB-approved validation study that demonstrated families can safely and reliably collect clinically meaningful blood samples at home. O'Ryan Health served as independent evaluator.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
O’Ryan Health competitors and assessment
Company assessmentEmerging players
- Function Health: Membership-based D2C lab testing platform offering comprehensive bloodwork and longitudinal tracking. Comparable consumer-facing subscription model for proactive lab testing, though adult-focused with national phlebotomy network rather than home collection.
- Babson Diagnostics: Retail-based capillary blood testing with miniaturized diagnostic instruments. Emerging peer in convenient, low-volume capillary sampling, with overlapping vision of decentralized diagnostics though delivered via retail rather than home.
Broad incumbents
- Quest Diagnostics: Large incumbent clinical laboratory offering mobile/at-home phlebotomy services (Quest Mobile) and direct-to-consumer testing through partners. Comparable in lab testing fulfillment and Medicaid contracting, but operates at vastly larger scale and not pediatric-specialized.
- Labcorp: Major clinical laboratory with at-home collection services (Labcorp At Home) and extensive pediatric test menu. Comparable in CLIA-certified pediatric lab testing and Medicaid contracting at scale; broad incumbent rather than niche pediatric specialist.
Direct peers
- Drawbridge Health: Maker of the OneDraw at-home capillary blood collection device. Comparable in offering a single-use, patient-friendly blood collection device for decentralized lab testing; directly overlaps with RedDrop ONE's value proposition.
- Tasso: Developer of the Tasso OnDemand at-home capillary blood collection device. Closest direct peer in pediatric/family-friendly at-home blood collection hardware and decentralized research; comparable model of enabling remote sample collection for clinical and research use.
- Seventh Sense Biosystems: Developer of the TAP (Touch Activated Phlebotomy) device for virtually painless capillary blood collection. Comparable in single-use, patient-friendly blood collection technology targeting decentralized testing and research applications.
- LetsGetChecked: D2C at-home lab testing company with subscription-based wellness panels and integrated logistics. Comparable GTM motion of direct-to-consumer ordering, kit shipping, CLIA-lab processing, and digital results delivery.
- Yourbio Health: Maker of the TAP II at-home capillary blood collection device used in clinical trials and remote research. Comparable in enabling decentralized clinical research through patient-administered blood collection kits shipped direct-to-home.
- Everlywell: Direct-to-consumer at-home lab testing platform with broad panels and parent-facing ordering model. Closest D2C at-home testing peer in business model and consumer funnel, though adult-focused rather than pediatric-specialized.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
O’Ryan Health social profiles
Digital presenceO’Ryan Health compliance and trust
Trust signalCompliance2 records
O’Ryan Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
O’Ryan Health leadership team
Management profileNumber of profiles
Profiles1 record
O’Ryan Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
O’Ryan Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about O’Ryan Health
What does O’Ryan Health do?
O'Ryan Health enables parents to collect small capillary blood samples from children at home using the RedDrop ONE device, then ships those samples via its Artemis logistics platform to CLIA-certified laboratory partners (Meridian Valley Lab, Celesta Health, Aura Genetics) for allergy, food sensitivity, and routine pediatric wellness testing. Results are returned to families through a secure Parent Portal and can be shared with the child's healthcare team. The company also provides at-home pediatric diagnostic infrastructure to state Medicaid Rural Health Transformation Programs and conducts IRB-approved pediatric research studies.
Is O’Ryan Health a public or private company?
O’Ryan Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was O’Ryan Health founded?
O’Ryan Health was founded in 2022. It employs 1 to 10 people.
Where is O’Ryan Health based?
O’Ryan Health is headquartered in Wellesley, United States, in the North America region.
How does O’Ryan Health make money?
Three revenue lines are on record. Direct-to-Parent Wellness Kit Sales are the primary driver. The others are medicaid and Government Program Contracts and healthcare Organization Partnerships.
Who are O’Ryan Health's main competitors?
Emerging players on record are Function Health and Babson Diagnostics. Broad incumbents are Quest Diagnostics and Labcorp. Direct peers are Drawbridge Health, Tasso, Seventh Sense Biosystems, LetsGetChecked, Yourbio Health and Everlywell.
Does O’Ryan Health have an API?
No public API is recorded for O’Ryan Health.
What industry is O’Ryan Health in?
O’Ryan Health's product category is Pediatric At-Home Diagnostic Testing. Its primary akta.pro industry code is HSABACAN, Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home), with a secondary code of HLAFAJAF, Pediatrics & Adolescent Medicine Practices. Its NAICS code is 62151 and its SIC code is 8082.